DE69127947T2 - Monoklonale Antikörper gegen menschliches IgE - Google Patents

Monoklonale Antikörper gegen menschliches IgE

Info

Publication number
DE69127947T2
DE69127947T2 DE69127947T DE69127947T DE69127947T2 DE 69127947 T2 DE69127947 T2 DE 69127947T2 DE 69127947 T DE69127947 T DE 69127947T DE 69127947 T DE69127947 T DE 69127947T DE 69127947 T2 DE69127947 T2 DE 69127947T2
Authority
DE
Germany
Prior art keywords
human ige
monoclonal antibodies
antibodies
immunoassays
employing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69127947T
Other languages
English (en)
Other versions
DE69127947D1 (de
Inventor
Shinji Nishimura
Shigenori Harada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of DE69127947D1 publication Critical patent/DE69127947D1/de
Publication of DE69127947T2 publication Critical patent/DE69127947T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/804Radioisotope, e.g. radioimmunoassay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/862Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgE or IgD
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
DE69127947T 1990-09-18 1991-04-24 Monoklonale Antikörper gegen menschliches IgE Expired - Fee Related DE69127947T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2249530A JP2988635B2 (ja) 1990-09-18 1990-09-18 ヒトIgEに対するモノクローナル抗体

Publications (2)

Publication Number Publication Date
DE69127947D1 DE69127947D1 (de) 1997-11-20
DE69127947T2 true DE69127947T2 (de) 1998-05-28

Family

ID=17194354

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69127947T Expired - Fee Related DE69127947T2 (de) 1990-09-18 1991-04-24 Monoklonale Antikörper gegen menschliches IgE

Country Status (9)

Country Link
US (2) US5478926A (de)
EP (1) EP0476226B1 (de)
JP (1) JP2988635B2 (de)
KR (1) KR0181948B1 (de)
AT (1) ATE159300T1 (de)
DE (1) DE69127947T2 (de)
DK (1) DK0476226T3 (de)
ES (1) ES2109242T3 (de)
GR (1) GR3025630T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0589840T3 (da) * 1992-09-24 2004-07-26 Novartis Ag Omdannede monoklonale antistoffer mod en immunoglobulinisotype
GB9220228D0 (en) * 1992-09-24 1992-11-04 Ciba Geigy Ag Reshaped monoclonal antibodies against an immunologlobulin isotype
US5958708A (en) * 1992-09-25 1999-09-28 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
US6066718A (en) * 1992-09-25 2000-05-23 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
JP3825798B2 (ja) * 1994-01-18 2006-09-27 ジェネンテク,インコーポレイテッド IgEアンタゴニストを用いる寄生虫感染症の治療法
US5716791A (en) 1996-05-09 1998-02-10 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US5932430A (en) * 1996-05-09 1999-08-03 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US7074586B1 (en) * 1999-06-17 2006-07-11 Source Precision Medicine, Inc. Quantitative assay for low abundance molecules
CA2404237C (en) * 2000-04-05 2010-01-26 University Of Tennessee Research Corporation Methods of investigating, diagnosing, and treating amyloidosis
US7244580B2 (en) * 2001-11-08 2007-07-17 The Regents Of The University Of California Epsilon immunoglobulin chain derived peptides for induction of anti-IgE antibodies
US20030109067A1 (en) * 2001-12-06 2003-06-12 Immunetech, Inc. Homogeneous immunoassays for multiple allergens
WO2004041865A2 (en) 2002-11-08 2004-05-21 Ablynx N.V. Stabilized single domain antibodies
US20060034845A1 (en) 2002-11-08 2006-02-16 Karen Silence Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
US9320792B2 (en) 2002-11-08 2016-04-26 Ablynx N.V. Pulmonary administration of immunoglobulin single variable domains and constructs thereof
DE10327399A1 (de) * 2003-06-18 2005-01-05 Carl Zeiss Jena Gmbh Verfahren und Messanordnung zur markierungsfreien Detektion von Bindungsereignissen zwischen Proteinen und oberflächengebundenen Antikörpern
US20210355237A1 (en) * 2018-09-21 2021-11-18 Riken ANTI-IgE ANTIBODY SPECIFICALLY BINDING TO MEMBRANE-BOUND IgE ANTIBODY OF IgE ANTIBODY-PRODUCING B CELLS AND METHOD FOR DIAGNOSING AND TREATING ALLERGIC SYMPTOMS USING THE SAME

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8606500A1 (es) * 1985-07-31 1986-04-01 Abello Alergia & Inmunologia Un metodo para determinar la presencia de ige especifica en sueros humanos
EP0259585B1 (de) * 1986-07-29 1993-06-09 Kishimoto, Tadamitsu, Prof. Monoklonale Antikörper gegen oberflächlichen IgE-Rezeptor, sowie Hybrid-Zellinien zu deren Herstellung und Verwendung

Also Published As

Publication number Publication date
DK0476226T3 (da) 1998-01-26
KR0181948B1 (ko) 1999-05-01
US5478926A (en) 1995-12-26
ES2109242T3 (es) 1998-01-16
EP0476226A1 (de) 1992-03-25
JP2988635B2 (ja) 1999-12-13
ATE159300T1 (de) 1997-11-15
KR920006005A (ko) 1992-04-27
US5583005A (en) 1996-12-10
GR3025630T3 (en) 1998-03-31
JPH04126094A (ja) 1992-04-27
EP0476226B1 (de) 1997-10-15
DE69127947D1 (de) 1997-11-20

Similar Documents

Publication Publication Date Title
DE69127947D1 (de) Monoklonale Antikörper gegen menschliches IgE
ATE154642T1 (de) Monoklonale antikörper gegen das mikrotubulusassoziierte protein tau.
DE69029015T2 (de) Antikörper gegen menschlichen Interleukin-6-Rezeptor
DE69429095T2 (de) Humanisierte antikoerper
EA200700083A1 (ru) Антитела, направленные против бета-амилоидного пептида, и способы их применения
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
IT1245748B (it) Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego
DE9321535U1 (de) Gewinnung und Kultivierung transformierter Zellen und Herstellung gegen sie gerichteter Antikörper
EP0444856A3 (en) Diagnostic assay for alzheimer's disease
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
EP0350690A3 (de) Neutralisation der in vitro- und in vivo-toxischen Eigenschaften von TNF-alfa durch monoklonale Antikörper und die davon abgeleiteten Fragmente
ATA111789A (de) Humaner monoklonaler antikörper und hybridom zur herstellung desselben
FI900230A0 (fi) Anti-idiotypa antikroppar mot antikroppar mot antigener med hoeg molekylvikt associerade till human melanoma.
AU5809290A (en) Monoclonal antibodies involved in alzheimer's disease, hybridomas secreting these monoclonal antibodies, antigen recognized by these antibodies, and their application
DE58908815D1 (de) Monoklonaler Antikörper gegen Pseudomonas aeruginosa, seine Herstellung und Verwendung.
ATE205255T1 (de) Spezifische antikörper gegen aktivierte plättchen,ihre herstellung und ihre verwendung in diagnose und therapie
IT1228881B (it) Anticorpo monoclonale specifico per l'epitopo dell'urochinasi prourichinasi corrispondente alla regione denominata gfd
ATE144286T1 (de) Monoklonale antikörper gegen den plasmin- antiplasmin komplex, verfahren zu ihrer herstellung sowie ihre verwendung
ATE86261T1 (de) Tumorassoziiertes antigen.
HUP0301085A2 (hu) Új peptid és alkalmazása szelektálási eljárásra
FR2646607B1 (fr) Anticorps monoclonaux anti-b2 microglobuline
ITTO911003A0 (it) Metodo rapido per l'identificazione dello s.aureus, kit diagnostico per l'esecuzione di tale metodo, anticorpi monoclonali contro la glucosaminidasi dello s. aureus e ibridoma per la produzione di tali anticorpi.
ATE455794T1 (de) Monoklonale antikörper gegen humane thymidylat- synthase und hybridomen zu derer herstellung
CA2151945A1 (en) Assay and treatment for demyelinating diseases such as multiple sclerosis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee